SCHEMBL30144962

SCHEMBL30144962

CSC1=N/C(=C\c2ccc3ncsc3c2)C(=O)N1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK1 P49759 17/20 0.60
▸ DYRK1A Q13627 16/20 0.60
▸ DYRK2 Q92630 16/20 0.60
▸ DYRK1B Q9Y463 16/20 0.60
▸ CLK4 Q9HAZ1 16/20 0.60
▸ DYRK3 O43781 14/20 0.60
▸ CLK2 P49760 14/20 0.60
▸ CLK3 P49761 11/20 0.60
▸ DYRK4 Q9NR20 10/20 0.60
▸ GSK3B P49841 6/20 0.60
▸ MAPT P10636 2/20 0.57
▸ GAA P10253 1/20 0.57
▸ CSNK2A2 P19784 3/20 0.55
▸ CSNK2B P67870 3/20 0.55
▸ CSNK2A1 P68400 3/20 0.55
▸ PIM1 P11309 1/20 0.55
▸ CSNK2A3 Q8NEV1 1/20 0.55
▸ HPGD P15428 1/20 0.54
▸ PIK3CD O00329 1/20 0.53
▸ PRKCB P05771 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23970084 1.00 CLK1 (0.60) CLK1DYRK1ADYRK2DYRK1BCLK4
SCHEMBL28842886 0.87 CLK1 (0.60) CLK1DYRK1ADYRK2DYRK1BCLK4
SCHEMBL30145002 0.87 CLK1 (0.60) CLK1DYRK1ADYRK2DYRK1BCLK4
SCHEMBL23510493 0.87 CLK1 (0.60) CLK1DYRK1ADYRK2DYRK1BCLK4
SCHEMBL23510637 0.86 CLK1 (0.64) CLK1DYRK1ADYRK2DYRK1BCLK4
SCHEMBL23970056 0.86 CLK1 (0.58) CLK1DYRK1ADYRK2DYRK1BCLK4
SCHEMBL25590185 0.84 CLK1 (0.64) CLK1DYRK1ADYRK2DYRK1BCLK4
SCHEMBL28843077 0.81 CLK1 (0.64) CLK1DYRK1ADYRK2DYRK1BCLK4
SCHEMBL23970074 0.81 CLK1 (0.64) CLK1DYRK1ADYRK2DYRK1BCLK4
SCHEMBL23970451 0.81 CLK1 (0.72) CLK1DYRK1ADYRK2DYRK1BCLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143185-A1 NEW IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 Perha Pharmaceuticals (FR) 2023-03-08 — — EP disclosed
CN-115515953-A Novel imidazolidinone derivatives as inhibitors of protein kinases, in particular DYRK1A, CLK1 and/or CLK4 珀哈制药公司 2022-12-23 — — CN disclosed
Send feedback